Experimental Group:FTZ 4 capsules each time (2.52g), 3 times a day

4 trials

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University

Conditions

HyperlipidemiaNonalcoholic fatty liver diseaseT2DMhypertension

Unknown Phase

A randomized, double-blind, placebo-controlled clinical study for FTZ in the treatment of hyperlipidemia

RecruitingChiCTR1900025935

The First Affiliated Hospital of Guangdong Pharmaceutical UniversityHyperlipidemia

Start: 2019-09-16Updated: 2022-11-07

A randomized, double-blind, placebo-controlled study for FTZ in patients with type 2 diabetes

RecruitingChiCTR1900025934

The First Affiliated Hospital of Guangdong Pharmaceutical UniversityT2DM

Start: 2019-09-16Updated: 2019-09-16

A randomized, double-blind, placebo-controlled clinical study for FTZ in the treatment of hypertension

RecruitingChiCTR1900025937

The First Affiliated Hospital of Guangdong Pharmaceutical Universityhypertension

Start: 2019-09-16Updated: 2019-09-16

A randomized, double-blind, placebo-controlled clinical study for FTZ in the treatment of patients with nonalcoholic fatty liver disease

RecruitingChiCTR1900025938

The First Affiliated Hospital of Guangdong Pharmaceutical UniversityNonalcoholic fatty liver disease

Start: 2019-09-16Updated: 2019-09-16